NCT07163832

Brief Summary

Gender incongruence is characterized by a marked and persistent incongruity between the gender with which a person identifies and their assigned sex. Behaviors and preferences that vary by sex do not, in and of themselves, justify the assignment of diagnoses in this group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for all trials

Timeline
0mo left

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
May 2025May 2026

Study Start

First participant enrolled

May 15, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2026

Expected
Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

12 months

First QC Date

September 1, 2025

Last Update Submit

September 1, 2025

Conditions

Keywords

Pediatric endocrinologyChild Psychiatry

Outcome Measures

Primary Outcomes (1)

  • Retrospective descriptive study of the population of transgender minors receiving medical support at the Strasbourg University Hospital

    Up to 1 year

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Minor patient (≥18 years old) who has been consulted for the first time for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)

You may qualify if:

  • Minor patient (≥18 years old)
  • First-time patient for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)
  • Patient (and/or their legal representative) who has not expressed opposition to the reuse of their data for scientific research purposes.

You may not qualify if:

  • Patient (and/or their representative) who has expressed opposition to the reuse of their data for scientific research purposes.
  • Patient aged over 18 at the first consultation
  • Patient with insufficient data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de pédiatrie 1 - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2025

First Posted

September 9, 2025

Study Start

May 15, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

May 15, 2026

Last Updated

September 9, 2025

Record last verified: 2025-09

Locations